Navigation Links
Neuland Labs Reports Financial Results For Fiscal Year 2013

HYDERABAD, India, May 10, 2013 /PRNewswire/ -- Neuland Laboratories Ltd., (NSE: NEULANDLAB; BOM: 524558) a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and contract manufacturing services to customers located in 85 countries, today announced financial results for the 2013 fiscal year (FY) ended March 31, 2013.

"Our initiatives to reduce costs and increase profitability gained momentum in FY 2013, and we are pleased to report record profits for the year," said Dr. D.R. Rao , Chairman and Managing Director of Neuland Labs .  "The reorganization of our business and accompanying capital infusion last year enabled us to reduce our financing costs and to realize greater efficiencies in our manufacturing operations.  We intend to continue our focus on achieving greater growth along with enhanced profitability in the new fiscal year."

Revenues for FY 2013 were $85.0 million (4.61 billion INR*) compared to FY 2012 revenues of $82.7 million (4.48 billion INR), an increase of 2.8%.  The increase in revenues primarily reflects gains in sales of the company's products and services from its API and Contract Research and Manufacturing businesses.

Neuland reported FY 2013 EBITDA of $11.3 million (614.5 million INR), compared to EBITDA of $8.9 million (483.5 million INR) in FY 2012, an increase of 27.1%.

After-tax profits in FY 2013 were $2.5 million (136.4 million INR), compared to after-tax profits in FY 2012 of $0.4 million (20.3 million INR).  

"During fiscal year 2013, we made further progress in building a strong foundation for future growth and profitability," commented Sucheth R. Davuluri, Chief Executive Officer of Neuland Labs .  "We are making good on our goal of strengthening our product mix with higher margin products and services, and we expect this trend to continue.  Our manufacturing collaboration with API Corporation (APIC), a healthcare unit of Mitsubishi Chemical Holdings Group, was a notable advance this year, and we believe this alliance will enable us to raise our profile in Japan while better serving our customers around the globe."

For a complete set of Neuland's FY 2013 and FY 2012 financial data, visit Laboratories is listed on India's National Stock Exchange under the symbol NEULANDLAB and on the Bombay Stock Exchange under code 524558 and the symbol Neuland.EO.* = Indian rupees

About Neuland Labs
For over 25 years Neuland Labs has been at the forefront of manufacturing APIs through its cGMP manufacturing facilities, working with customers in 85 countries. Neuland Labs has developed more than 300 processes and 60 APIs, and it has filed more than 45 US drug master files (DMFs), 14 EU CEPs and a total of more than 400 DMFs worldwide. Its manufacturing facilities are inspected and approved by the US FDA and other leading regulatory agencies. Its record of quality manufacturing and reliability is highlighted by cGMP certifications that include the FDA, TGA, EDQM, German Health Authority, ISO 14001, ISO 27001 and OHSAS 18001. For more information, visit Laboratories Ltd. US MediaNS Viswanathan BLL Partners/Brandwidth SolutionsChief Financial OfficerBarbara Lindheim+91 40 30211600+1 212 584-2276

SOURCE Neuland Laboratories Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Neuland Labs Strengthens Commitment to Japanese Market With New Manufacturing Collaboration With Mitsubishi Healthcare Unit API Corporation
2. Neuland Labs Reports Second Quarter Fiscal Year 2013 Financial Results
3. Neuland Labs Reports First Quarter Fiscal Year 2013 Financial Results
4. Neuland Labs Reports Financial Results For Fiscal Year 2012
5. Omeros Corporation Reports First Quarter 2013 Financial Results
6. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 First Quarter Financial Results
7. CareFusion Reports Third Quarter Fiscal 2013 Results
8. Misonix Reports Nine Months Fiscal 2013 Financial Results
9. Optimer Reports First Quarter 2013 Financial Results
10. American Pacific Reports Fiscal 2013 Second Quarter Results; Increases Full Year Guidance
11. Alimera Sciences Reports First Quarter 2013 Financial Results
Post Your Comments:
(Date:11/24/2015)... -based Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ) ... and dispensing of novel compounded pharmaceuticals.  The company,s ... ophthalmology, urology, sinus and integrative medicine.  Imprimis dispenses ... facilities located in California , ... Jersey and Pennsylvania.  For more information ...
(Date:11/24/2015)... NEW YORK , Nov. 24, 2015  Eyewear brand ... sunglasses in collaboration with U2 lead singer and activist Bono ... campaign to prevent vision impairment and blindness in more than ... --> Revo will donate $10 from the sale ... Visibility" collection, up to a total of $10 million to ...
(Date:11/24/2015)... Nov. 24, 2015 Xencor, Inc. (NASDAQ: ... antibodies for the treatment of autoimmune diseases, asthma and ... Dahiyat , Ph.D., president and chief executive officer, will ... , 2015 Piper Jaffray Healthcare Conference Date: Tuesday, December ... New York, NY     , Oppenheimer ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... ... Bibliomotion is thrilled to announce the launch of UNCONVENTIONAL LEADERSHIP: ... Nancy M. Schlichting, Chief Executive Officer of Henry Ford Health System (November 24, ... patients and their families, shaped my desire to improve the system of care. I ...
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Kevin Day, local family chiropractor in ... less this holiday season. During the Indiana winter months, Vitamin D deficiency can ... team at AlignLife want to help provide the tools needed to combat it this ...
(Date:11/24/2015)... ... 2015 , ... All her life, Don Peck’s mother wondered if she was a descendant of ... been. After a 25-year search for information, Don and his aunt discovered that she ... name. Turns out, it was Don’s father who was descended from not one, but ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... engineer of patented products, announces Fragrance by Marcelle, a cosmetic invention which offers ... Perfume & Fragrance Manufacturing Market in the US is worth $3 billion annually," ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... of the Business Action on Health Awards, bestowed annually to the world’s best ... five commended companies at Global Health Council’s Landscape Symposium held in Washington D.C ...
Breaking Medicine News(10 mins):